Related by context. Frequent words. (Click for all words.) 62 FDA Accepts 61 Presents Positive 61 Completes Enrollment 60 submitted Biologics License 59 Announces Initiation 59 Initiates Phase 59 Drug Candidate 59 FDA Clears 58 NASDAQ SHPGY 58 Nasdaq REGN 57 Kuvan R 57 Inc. Nasdaq SEPR 57 Initiate Phase 57 Aradigm Corporation 57 liposomal formulation 56 QLTI 56 Inc. Nasdaq IMGN 56 Announces Immediate Availability 56 Pivotal Phase III 56 NASDAQ CRXL 55 Barrier Therapeutics Inc. 55 Nasdaq ALTH 54 R sorafenib tablets 54 Transcept Pharmaceuticals 54 Recombinant Human 54 Inc Therapeutic Competitors 54 PHARM 54 GlaxoSmithKline plc GSK 53 OPTR 53 NASDAQ LGND 53 NYSE MYL 53 ALIM 53 Announces Presentation 53 BPAX 53 TLR9 agonist 53 Report companiesandmarkets.com adds 53 Connetics Corporation 53 Nasdaq BDSI 53 Fibrocell Science Inc. 53 Inc. NASDAQ MRNA 53 Patient Enrollment 52 IPXL 52 AUXL 52 humanized anti 52 mediate RNAi 52 ISPH 52 Patent Covering 52 ISTA Pharmaceuticals 52 RegeneRx Biopharmaceuticals Inc. 52 DepoMed 52 topical anti infective 51 Release Date Announced 51 GVAX R 51 Genelabs Technologies Inc. 51 Nasdaq VRTX 51 Exploit collaboration 51 Files Shelf Registration Statement 51 Novelos Therapeutics Inc. 51 Factor VIIa 51 DVAX 51 Pivotal Phase 51 OncoGenex Pharmaceuticals Inc. 51 Cyclacel Pharmaceuticals Inc. 51 Flamel Technologies 51 Skymark Research Initiates Independent 50 OncoGenex Pharmaceuticals 50 Tesetaxel 50 EPIX Pharmaceuticals Inc. 50 Inhibits 50 Generex Biotechnology Corp. 50 MNTA 50 Anika Therapeutics 50 fibrosis IPF 50 Vicuron Pharmaceuticals 50 Nastech Pharmaceutical Company 50 AKRX 50 Indevus Pharmaceuticals 50 ACHN 50 Multiple Vulnerabilities 49 targeting CD# 49 IDIX 49 IMPAX Laboratories Inc. 49 ADVENTRX Pharmaceuticals Inc. 49 By Tim Conneally 49 NASDAQ BPAX 49 Metabasis Therapeutics 49 malignant infectious 49 DYAX 49 OXGN 49 VRUS 49 Iomai Corporation 49 ENZN 49 CRME 49 MKC# 49 Acute Myeloid Leukemia AML 49 BY TREVOR HUGHES 49 CADX 49 BioSpecifics Technologies Corp. 49 IMMU 49 Sunesis Pharmaceuticals 49 NASDAQ SVNT